Panel discussion/ Q&A

4.30pm – 5pm GMT, 6 November 2024 ‐ 30 mins

Panel discussion

Session Three: Data, digital technologies and real-world evidence

Session Chair: Kathy Williams, Head of Global Regulatory Policy and Intelligence, AstraZeneca, and Vice-Chair, BIA Regulatory Affairs Advisory Committee